International Operations Offer Continued Strength to Tilray Brands (TLRY)

Tilray Brands Inc. (NASDAQ:TLRY) is one of the 10 best tobacco and cigarette stocks to invest in.

There are obvious reasons to be optimistic about this medicinal cannabis play. On April 2, Bill Kirk from Roth Capital upgraded Tilray Brands Inc. (NASDAQ:TLRY) from Neutral to Buy while maintaining a price target of $10. The reasons put forward by the analyst for the upgrade included the stability of the company’s Canadian business, a turnaround in its international operations, and an improvement in the beverages segment.

The analyst also noted that the stock price of Tilray is back at levels last recorded in July 2025. The company’s fundamentals have turned positive, and chances of regulatory change have increased, according to the analyst.

On April 2, Alliance Global reduced the price target on Tilray Brands Inc. (NASDAQ:TLRY) from $9 to $7 while maintaining a Neutral rating on the shares. The firm reflected on Tilray’s third-quarter sales miss. Despite that, the stock offers attractive exposure to an expanding medicinal cannabis market. The company benefited from its cost-saving initiatives, resulting in EBITDA exceeding expectations. According to Alliance Global, uncertainty about the ban on hemp was the rationale for the price target reduction.

Tilray Brands Inc. (NASDAQ:TLRY) is involved in growing, researching, and selling medicinal cannabis products. Alongside this, it markets and resells wellness and pharmaceutical products, beverages, and food products made of hemp. Additionally, it also provides goods for entertainment. Its products are sold through several channels, including pharmacies, retailers, and wholesalers.

READ NEXT: 33 Stocks That Should Double in 3 Years and 15 Stocks That Will Make You Rich in 10 Years.

Disclosure: None. Follow Insider Monkey on Google News.